Catalogo dei prodotti della ricerca

GASPARRI, MARIA LUISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.211
EU - Europa 593
AS - Asia 466
AF - Africa 30
SA - Sud America 6
OC - Oceania 1
Totale 4.307
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.193
IT - Italia 245
SG - Singapore 180
IN - India 136
SE - Svezia 113
CN - Cina 107
FI - Finlandia 76
DE - Germania 45
UA - Ucraina 24
TG - Togo 22
BG - Bulgaria 20
GB - Regno Unito 17
CA - Canada 16
IE - Irlanda 16
RO - Romania 11
BE - Belgio 10
ID - Indonesia 10
IR - Iran 9
PK - Pakistan 9
AR - Argentina 6
CH - Svizzera 6
KR - Corea 4
NL - Olanda 4
TR - Turchia 4
SA - Arabia Saudita 3
SC - Seychelles 3
ZA - Sudafrica 3
FR - Francia 2
MU - Mauritius 2
RS - Serbia 2
AU - Australia 1
CZ - Repubblica Ceca 1
HU - Ungheria 1
KZ - Kazakistan 1
MX - Messico 1
MY - Malesia 1
PA - Panama 1
TJ - Tagikistan 1
VN - Vietnam 1
Totale 4.307
Salva come PNG Salva come JPEG
Città #
Fairfield 626
Ashburn 265
Woodbridge 262
Houston 243
Seattle 214
Cambridge 186
Wilmington 180
Chandler 169
Dearborn 144
Singapore 122
Rome 115
Ann Arbor 99
Princeton 88
Plano 71
San Paolo di Civitate 60
Millbury 48
Beijing 47
San Diego 42
Lawrence 38
Santa Clara 37
Andover 27
Boston 26
Lomé 22
Sofia 20
Helsinki 17
Dublin 16
Bremen 11
San Mateo 11
Brussels 10
Des Moines 10
Jakarta 10
Norwalk 10
Milan 9
Nanjing 9
New York 9
Falls Church 8
Kunming 8
Jacksonville 7
Bühl 6
Cagliari 6
Federal 6
Hefei 6
Bern 5
Fremont 5
Toronto 5
Antalya 4
Jinan 4
Monterotondo 4
Nanchang 4
Ottawa 4
Phoenix 4
Changchun 3
Frankfurt am Main 3
Guangzhou 3
Jeddah 3
Shanghai 3
Wuhan 3
Auburn Hills 2
Baotou 2
Belgrade 2
Boardman 2
Dallas 2
Falkenstein 2
Fuzhou 2
Grafing 2
Gunzenhausen 2
Hyderabad 2
Indianapolis 2
Kilburn 2
Leawood 2
London 2
Madison 2
Mannheim 2
Mashhad 2
Montréal 2
Munich 2
Nelson 2
North York 2
Pagani 2
Perugia 2
Port Louis 2
Redmond 2
Reggio Emilia 2
Shenyang 2
Silverton 2
Stornara 2
Acerra 1
Almaty 1
Ashland 1
Buffalo 1
Canberra 1
Chicago 1
Civita Castellana 1
Dushanbe 1
Florence 1
Fulham 1
Hanoi 1
Hebei 1
Kashan 1
Latina 1
Totale 3.449
Salva come PNG Salva come JPEG
Nome #
Bevacizumab-based chemotherapy triggers immunological effects in responding multi-treated recurrent ovarian cancer patients by favoring the recruitment of effector t cell subsets 132
Bulky mesonephric adenocarcinoma of the uterine cervix treated with neoadjuvant chemotherapy and radical surgery: report of the first case 106
Type B versus Type C Radical Hysterectomy After Neoadjuvant Chemotherapy in Locally Advanced Cervical Carcinoma: A Propensity-Matched Analysis 105
Sentinel node mapping in cervical and endometrial cancer: indocyanine green versus other conventional dyes. A meta-analysis 91
Advances in anti-angiogenic agents for ovarian cancer treatment: the role of trebananib (AMG 386) 90
MiRNAs and their interplay with PI3K/AKT/mTOR pathway in ovarian cancer cells. a potential role in platinum resistance 90
Laparotomic myomectomy in the 16th week of pregnancy: a case report. 89
PARP inhibition: a promising therapeutic target in ovarian cancer 86
Beyond circulating microRNA biomarkers. urinary microRNAs in ovarian and breast cancer 85
Is there a real standard for stage IVa cervical cancer? 84
Past, present and future strategies of immunotherapy in gynecological malignancies 84
Current knowledge of miRNAs as biomarkers in breast cancer 81
Surgical treatment of an isolated omental cervical cancer recurrence: Report of a case and review of the literature 81
Dealing naturally with stumbling blocks on highways and byways of TRAIL induced signaling. 79
Effects of unilateral ovariectomy on female fertility outcome 79
Efficacy and toxicity of bevacizumab in recurrent ovarian disease: an update meta-analysis on phase III trials 78
Cediranib in ovarian cancer. state of the art and future perspectives 76
Current knowledge and open issues regarding Bevacizumab in gynaecological neoplasms 74
Circulating tumor cells as trigger to hematogenous spreads and potential biomarkers to predict the prognosis in ovarian cancer 73
Minimal invasive approaches for large ovarian cysts: a careful choice 72
Endometrial and cervical cancer patients with multiple sentinel lymph nodes at laparoscopic ICG mapping: How many are enough? 72
Response criteria can be misleading when drawing conclusion regarding neoadjuvant chemotherapy in advanced ovarian cancer 71
Thrombotic thrombocytopenic purpura during pregnancy versus imitator of preeclampsia 71
Ovarian cancer: interplay of vitamin D signaling and miRNA action 70
Effect of neoadjuvant chemotherapy on primary treatment interval in patients with advanced ovarian cancer 69
Drugs from Marine Sources: Modulation of TRAIL Induced Apoptosis in Cancer Cells. 68
The Immunobiology of Cancer: From Tumor Escape to Cancer Immunoediting Towards Immunotherapy in Gynecologic Oncology 64
Anticancer activity of essential oils: targeting of protein networks in cancer cells 64
Let's think twice before abandoning fibrillar oxidized regenerated cellulose 63
Immunobiology of solid cancers: cellular and molecular pathways as potential diagnostic and therapeutic targets 62
Olaparib, PARP1 inhibitor in ovarian cancer 62
null 61
Is miR-34a a well-equipped swordsman to conquer temple of molecular oncology? 59
Monoclonal antibodies in gynecological cancer: a critical point of view. 59
PI3K/AKT/mTOR pathway in ovarian cancer treatment: are we on the right track? 59
Surgical treatment of recurrent endometrial cancer: time for a paradigm shift 59
Implementation of laparoscopic approach for type B radical hysterectomy: A comparison with open surgical operations. 58
Feasibility and safety of type C2 extraperitoneal radical hysterectomy for locally advanced cervical cancer. 57
Bmi is a key prognostic factor in stage iiic-iv ovarian cancer diagnosed prior 65 years old: a 10-year survival analysis 57
Vaginal Reconstruction with the Abbè-McIndoe Technique: From Dermal Grafts to Autologous in Vitro Cultured Vaginal Tissue Transplant 55
Interaction between treg cells and angiogenesis: A dark double track 54
null 54
null 54
null 53
null 52
Laparoscopic sentinel lymph node mapping in endometrial cancer 51
null 51
null 50
null 50
null 49
null 49
null 49
null 48
null 48
First case of isolated vaginal metastasis from breast cancer treated by surgery 47
CLINICAL OUTCOME OF SECONDARY SURGERY IN RECURRENT ENDOMETRIAL CANCER 47
null 47
Monoclonal antibodies therapies for ovarian cancer. 46
null 46
null 45
Immunologic Systemic Effect of Neoadjuvant Chemotherapy Requires Investigation Before Tumor-Associated Lymphocytes Can Be Introduced in Breast Cancer Treatment Algorithm 44
Incorporating parp-inhibitors in primary and recurrent ovarian cancer. A meta-analysis of 12 phase II/III randomized controlled trials 43
null 36
Sentinel node mapping vs. sentinel node mapping plus back-up lymphadenectomy in high-risk endometrial cancer patients. Results from a multi-institutional study 29
null 24
null 24
Factors predicting morbidity in surgically-staged high-risk endometrial cancer patients 24
null 23
HEPATIC SURGERY DURING CYTOREDUCTION FOR PRIMARY OR RECURRENT OVARIAN CANCER 20
null 20
null 20
Laparoscopic indocyanine green sentinel lymph node mapping in endometrial cancer. Papadia A, Imboden S, Siegenthaler F, Gasparri ML, Mohr S, Lanz S, Mueller MD. 19
Sentinel lymph node mapping in patients with stage I endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc99m with blue dye versus indocyanine green fluorescent dye. 18
Il ruolo delle antracicline liposomiali non peghilate nei tumori ginecologici. 17
A TEN-YEAR EXPERIENCE OF HEPATIC SURGERY DURING CYTOREDUCTION FOR PRIMARY OR RECURRENT OVARIAN CANCER 17
Cervical length after cerclage: comparison between laparoscopic and vaginal approach 17
null 17
Sentinel lymph node mapping in endometrial cancer: comparison of fluorescence dye with traditional radiocolloid and blue 13
Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm) 12
Computed tomography based radiomics as a predictor of survival in ovarian cancer patients: a systematic review 12
Hysterectomy alone vs. hysterectomy plus sentinel node mapping in endometrial cancer: perioperative and long-term results from a propensity-score based study 11
Endometrial cancer and BRCA mutations: a systematic review 11
Oleuropein Mediated Targeting of Signaling Network in Cancer. 11
FIGO stage IIIC endometrial cancer identification among patients with complex atypical hyperplasia, grade 1 and 2 endometrioid endometrial cancer: laparoscopic indocyanine green sentinel lymph node mapping versus frozen section of the uterus, why get around the problem? 11
Accuracy of Sentinel Lymph Node Mapping After Previous Hysterectomy in Patients with Occult Cervical Cancer. 10
The efficacy of fibrin sealant patches in reducing the incidence of lymphatic morbidity after radical lymphadenectomy: A meta-analysis 10
The combination of preoperative PET/CT and sentinel lymph node biopsy in the surgical management of early-stage cervical cancer 10
Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: a systematic review 9
Whole-body composition features by computed tomography in ovarian cancer: pilot data on survival correlations 9
The CORONIS trial on caesarean section. 9
Is it time to consider the sentinel lymph node mapping the new standard in endometrial cancer? 9
When Does Neoadjuvant Chemotherapy Really Avoid Radiotherapy? Clinical Predictors of Adjuvant Radiotherapy in Cervical Cancer. 8
Real-Time Fluorescent Sentinel Lymph Node Mapping with Indocyanine Green in Women with Previous Conization Undergoing Laparoscopic Surgery for Early Invasive Cervical Cancer: Comparison with Radiotracer ± Blue Dye 8
Evaluating long-term outcomes of three approaches to retroperitoneal staging in endometrial cancer 7
Doppler Ultrasound Flow Evaluation of the Uterine Arteries Significantly Correlates with Tumor Size in Cervical Cancer Patients. 7
From Conventional Radiotracer Tc-99m with Blue Dye to Indocyanine Green Fluorescence: A Comparison of Methods Towards Optimization of Sentinel Lymph Node Mapping in Early Stage Cervical Cancer for a Laparoscopic Approach. 6
Tertiary cytoreduction for recurrent endometrial cancer 5
Self-responsibility for Our Good Health. 4
Hepatic resection during cytoreductive surgery for primary or recurrent epithelial ovarian cancer. 3
Laparoscopic Indocyanine Green Sentinel Lymph Node Mapping in Endometrial Cancer. 2
Totale 4.594
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.726
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.726
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.021 0 0 0 0 134 230 220 141 140 78 43 35
2020/2021275 32 44 14 25 4 15 2 26 39 34 24 16
2021/2022765 20 32 73 24 102 29 4 82 49 68 114 168
2022/2023670 164 158 32 66 59 70 9 35 46 4 16 11
2023/2024350 20 50 20 32 37 39 5 43 3 27 26 48
2024/2025226 27 50 61 27 61 0 0 0 0 0 0 0
Totale 4.598